Attached files
| file | filename |
|---|---|
| 8-K - COLGATE-PALMOLIVE COMPANY 8-K - COLGATE PALMOLIVE CO | a50616769.htm |
| EX-99.1 - EXHIBIT 99.1 - COLGATE PALMOLIVE CO | a50616769ex99-1.htm |
EXHIBIT 99.2
Colgate-Palmolive Company
Segment Information
(Reclassified)
(Dollars in Millions) (Unaudited)
| Three Months Ended | ||||||||||||
| June 30, | September 30, | December 31, | ||||||||||
| 2012 | 2012 | 2012 | ||||||||||
| Net sales | ||||||||||||
| Oral, Personal and Home Care | ||||||||||||
| North America | $ | 727 | $ | 766 | $ | 754 | ||||||
| Latin America | 1,300 | 1,276 | 1,255 | |||||||||
| Europe/South Pacific | 850 | 865 | 848 | |||||||||
| Greater Asia/Africa | 859 | 897 | 870 | |||||||||
| Total Oral, Personal and Home Care | 3,736 | 3,804 | 3,727 | |||||||||
| Pet Nutrition | 531 | 528 | 559 | |||||||||
| Total Net sales | $ | 4,267 | $ | 4,332 | $ | 4,286 | ||||||
| Years ended December 31, | |||||||||||||||||||
| 2012 | 2011 | 2010 | 2009 | 2008 | |||||||||||||||
| Net sales | |||||||||||||||||||
| Oral, Personal and Home Care | |||||||||||||||||||
|
North America(1) |
$ | 2,971 | $ | 2,878 | $ | 2,880 | $ | 2,828 | $ | 2,739 | |||||||||
| Latin America | 5,032 | 4,895 | 4,386 | 4,441 | 4,201 | ||||||||||||||
| Europe/South Pacific | 3,417 | 3,508 | 3,220 | 3,271 | 3,582 | ||||||||||||||
| Greater Asia/Africa | 3,505 | 3,281 | 2,998 | 2,655 | 2,660 | ||||||||||||||
| Total Oral, Personal and Home Care | 14,925 | 14,562 | 13,484 | 13,195 | 13,182 | ||||||||||||||
| Pet Nutrition(2) | 2,160 | 2,172 | 2,080 | 2,132 | 2,148 | ||||||||||||||
| Total Net sales | $ | 17,085 | $ | 16,734 | $ | 15,564 | $ | 15,327 | $ | 15,330 | |||||||||
(1) Net sales in the U.S. for Oral, Personal and Home Care were $2,669, $2,567, $2,591, $2,577 and $2,490 in 2012, 2011, 2010, 2009 and 2008, respectively.
(2) Net sales in the U.S. for Pet Nutrition were $1,052, $1,032, $1,025, $1,071 and $1,082 in 2012, 2011, 2010, 2009 and 2008, respectively.
EXHIBIT 99.2
Colgate-Palmolive Company
Segment Information
(Reclassified)
(Dollars in Millions) (Unaudited)
| Three months ended | ||||||||||||
| June 30, | September 30, | December 31, | ||||||||||
| 2012 | 2012 | 2012 | ||||||||||
| Operating profit | ||||||||||||
| Oral, Personal and Home Care | ||||||||||||
| North America | $ | 190 | $ | 213 | $ | 230 | ||||||
| Latin America | 373 | 377 | 354 | |||||||||
| Europe/South Pacific | 179 | 198 | 187 | |||||||||
|
Greater Asia/Africa |
220 | 231 | 215 | |||||||||
| Total Oral, Personal and Home Care | 962 | 1,019 | 986 | |||||||||
| Pet Nutrition | 145 | 147 | 149 | |||||||||
| Corporate | (125 | ) | (139 | ) | (193 | ) | ||||||
| Total Operating profit | $ | 982 | $ | 1,027 | $ | 942 | ||||||
| Years ended December 31, | ||||||||||||||||||||
| 2012 | 2011 | 2010 | 2009 | 2008 | ||||||||||||||||
| Operating profit | ||||||||||||||||||||
| Oral, Personal and Home Care | ||||||||||||||||||||
| North America | $ | 810 | $ | 768 | $ | 849 | $ | 810 | $ | 665 | ||||||||||
| Latin America | 1,454 | 1,437 | 1,330 | 1,393 | 1,205 | |||||||||||||||
| Europe/South Pacific | 747 | 715 | 742 | 748 | 746 | |||||||||||||||
| Greater Asia/Africa | 886 | 807 | 767 | 631 | 527 | |||||||||||||||
| Total Oral, Personal and Home Care | 3,897 | 3,727 | 3,688 | 3,582 | 3,143 | |||||||||||||||
| Pet Nutrition | 589 | 560 | 559 | 555 | 542 | |||||||||||||||
| Corporate | (597 | ) | (446 | ) | (758 | ) | (522 | ) | (584 | ) | ||||||||||
|
Total Operating profit |
$ | 3,889 | $ | 3,841 | $ | 3,489 | $ | 3,615 | $ | 3,101 | ||||||||||
EXHIBIT 99.2
Colgate-Palmolive Company
Segment Information
(Reclassified)
(Dollars in Millions) (Unaudited)
| Years ended December 31, | |||||||||||||||||||
| 2012 | 2011 | 2010 | 2009 | 2008 | |||||||||||||||
| Capital expenditures | |||||||||||||||||||
| Oral, Personal and Home Care | |||||||||||||||||||
| North America | $ | 43 | $ | 53 | $ | 57 | $ | 62 | $ | 42 | |||||||||
| Latin America | 237 | 195 | 138 | 105 | 112 | ||||||||||||||
| Europe/South Pacific | 71 | 64 | 80 | 86 | 64 | ||||||||||||||
| Greater Asia/Africa | 104 | 119 | 111 | 91 | 157 | ||||||||||||||
| Total Oral, Personal and Home Care | 455 | 431 | 386 | 344 | 375 | ||||||||||||||
| Pet Nutrition | 37 | 32 | 81 | 156 | 224 | ||||||||||||||
| Corporate | 73 | 74 | 83 | 75 | 85 | ||||||||||||||
| Total Capital expenditures | $ | 565 | $ | 537 | $ | 550 | $ | 575 | $ | 684 | |||||||||
| Years ended December 31, | |||||||||||||||||||
| 2012 | 2011 | 2010 | 2009 | 2008 | |||||||||||||||
| Depreciation and amortization | |||||||||||||||||||
| Oral, Personal and Home Care | |||||||||||||||||||
| North America | $ | 50 | $ | 56 | $ | 56 | $ | 59 | $ | 54 | |||||||||
| Latin America | 91 | 92 | 85 | 77 | 88 | ||||||||||||||
| Europe/South Pacific | 85 | 82 | 67 | 67 | 70 | ||||||||||||||
| Greater Asia/Africa | 81 | 79 | 69 | 63 | 61 | ||||||||||||||
| Total Oral, Personal and Home Care | 307 | 309 | 277 | 266 | 273 | ||||||||||||||
| Pet Nutrition | 50 | 51 | 45 | 36 | 32 | ||||||||||||||
| Corporate | 68 | 61 | 54 | 49 | 43 | ||||||||||||||
| Total Depreciation and amortization | $ | 425 | $ | 421 | $ | 376 | $ | 351 | $ | 348 | |||||||||
EXHIBIT 99.2
Colgate-Palmolive Company
Segment Information
(Reclassified)
(Dollars in Millions) (Unaudited)
| At December 31, | |||||||||||||||||||
| 2012 | 2011 | 2010 | 2009 | 2008 | |||||||||||||||
| Identifiable assets | |||||||||||||||||||
| Oral, Personal and Home Care | |||||||||||||||||||
| North America | $ |
2,157 |
$ |
2,247 |
$ |
2,196 |
$ |
2,237 |
$ | 1,955 | |||||||||
| Latin America |
4,288 |
3,677 |
3,127 |
3,312 |
2,592 | ||||||||||||||
| Europe/South Pacific | 3,649 | 3,555 | 2,775 | 2,647 | 2,620 | ||||||||||||||
| Greater Asia/Africa | 2,169 | 2,069 | 1,943 | 1,760 | 1,704 | ||||||||||||||
| Total Oral, Personal and Home Care | 12,263 | 11,548 | 10,041 | 9,956 | 8,871 | ||||||||||||||
| Pet Nutrition | 1,045 | 1,078 | 1,081 | 1,127 | 1,025 | ||||||||||||||
| Corporate(3) | 86 | 98 | 50 | 51 | 83 | ||||||||||||||
| Total Identifiable assets(4) | $ | 13,394 | $ | 12,724 | $ | 11,172 | $ | 11,134 | $ | 9,979 | |||||||||
(3) In 2012, Corporate identifiable assets primarily consist of derivative instruments (67%) and investments in equity securities (28%). In 2011, Corporate identifiable assets primarily consist of derivative instruments (73%) and investments in equity securities (22%). In 2010, Corporate identifiable assets primarily consist of derivative instruments (44%) and investments in equity securities (48%). In 2009, Corporate identifiable assets primarily consist of derivative instruments (44%) and investments in equity securities (46%). In 2008, Corporate identifiable assets primarily consist of derivative instruments (66%) and investments in equity securities (27%).
(4) Long-lived assets in the U.S., primarily property, plant and equipment and goodwill and other intangibles represented approximately one-third of total long-lived assets of $8,066, $7,926, $7,116, $6,795 and $6,182 in 2012, 2011, 2010, 2009 and 2008, respectively.